Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies

CONCLUSION: Autoantibodies appear to increase CVD risk; however, the magnitude of the increase and the types of CVD outcomes affected are still unclear. Prospective studies with larger populations are required to further understand and quantify the association, including the causal pathway, between specific risk factors and CVD outcomes in RA patients.PMID:34262386 | PMC:PMC8246480 | DOI:10.1177/11795441211028751

Source: Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders - July 15, 2021 Category: Orthopaedics Authors: Mir Sohail Fazeli Vadim Khaychuk Keith Wittstock Boris Breznen Grace Crocket Mir-Masoud Pourrahmat Leticia Ferri Source Type: research